COMP <GO>
BKV vs XOM // EV/EBITDA & P/E VALUATION
BKV Corporation (NYSE) VS. Exxon Mobil Corporation (NYSE) • 15-METRIC TALLY: BKV 6
— XOM 6
▲ EV/EBITDA & P/E VALUATION LEADER: BKV
LAST: $20.94 (-1.09%) • MKT CAP: $2.29B
valuation
5.3x
LAST: $183.29 (+0.70%) • MKT CAP: $753.67B
valuation
13.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BKV VS. XOM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BKV | XOM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.00% | 9.86% | -0.86 | XOM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 5.3x | 13.9x | -8.57 | BKV | /valuation <GO> |
| Free Cash Flow Yield | -1.08% | 2.51% | -3.59 | XOM | /fcf-yield <GO> |
| Operating Margin | 26.60% | 10.96% | +15.64 | BKV | /operating-margins <GO> |
| Net Profit Margin | 15.70% | 7.57% | +8.13 | BKV | /net-margins <GO> |
| Revenue Growth (YoY) | 41.60% | -4.40% | +46.00 | BKV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.20% | -2.20 | XOM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.37 | 4.65 | -3.28 | XOM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | BKV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.22% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 67.1 | -28.09 | XOM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.28 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.8x | 14.3x | -3.54 | BKV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.29B | $753.67B | -$751.38B | XOM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BKV REV | XOM REV | BKV GROSS % | XOM GROSS % | BKV FCF | XOM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.14B | $332.24B | — | — | -$24.7M | $23.61B |
| FY 2024 | $805.7M | $349.58B | — | — | $10.0M | $30.72B |
| FY 2023 | $1.01B | $344.58B | — | — | $260.3M | $33.45B |
| FY 2022 | — | $413.68B | — | — | — | $58.39B |
| FY 2021 | — | $285.64B | — | — | — | $36.05B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BKV // BETA —
XOM // BETA 0.28